【Medindia】Amaran Biotech Wins "Best CDMO in Automated Aseptic Filling"

【Macau Business】Amaran Biotech Wins “Best CDMO in Automated Aseptic Filling”

Amaran Biotech Wins "Best CDMO in Automated Aseptic Filling" Honored at Taiwan Biopharma Excellence Awards 2025

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was honored with the "Best CDMO in Automated Aseptic Filling" award at the Taiwan Biopharma Excellence Awards 2025, held yesterday (March 26) at the Hilton Taipei Sinban. Organized by the renowned international consulting firm IMAPAC, the award recognizes Amaran Biotech’s outstanding contribution to advancing automated aseptic filling solutions in the biopharmaceutical sector.

【MENAFN】Amaran Biotech Wins "Best CDMO In Automated Aseptic Filling"

Superior WFI Quality, Exceptional Products

Water for Injection (WFI) is a high-purity water essential to the pharmaceutical, biotech manufacturing, and related industries. Unlike regular purified water, WFI must meet the strictest pharmacopeial standards, such as those set by the United States Pharmacopeia (USP). As a fundamental carrier that may be directly injected into the human body, WFI requires significantly higher purity than industrial or potable water.

【geneonline】Taiwan’s Amaran Biotech Takes Top Spot at 2025 Asia-Pacific Biopharma Awards

【Yahoo!Finance】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

【Macau Business】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

【The Korea Bizwire】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025 Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” Honor

New-generation Contract Development and Manufacturing Organization (CDMO) Amaran Biotech has been awarded the prestigious “Bioprocessing Excellence in Taiwan” honor at the Asia-Pacific Biopharma Excellence Awards 2025 ceremony, hosted by renowned consulting firm IMAPAC in Singapore on March 12.

【BioSpectrum Asia】Taiwan's Amaran Biotech signs MoU with Nippon to expand CDMO business

【MedPath】Amaran Biotech Partners with Nippon Fine Chemical to Advance Nanoparticle-Based Drug Manufacturing